Steris (STE) — insider trading
Health Care · NYSE
Steris (STE) has 77 reported SEC Form 4 insider transactions in our data, including 5 open-market sales among the most recent 77 (latest 2026-10-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Burton Karen L | Officer (Sr. Vice Pres., CFO) | Shares withheld for taxes / exercise cost | 228 | — | $0 | Form 4 |
| 2026-08-12 | Sohi Mohsen | Director | Option exercise / conversion (derivative) | 4,058 | — | $0 | Form 4 |
| 2026-08-12 | Sohi Mohsen | Director | Open-market sale | 4,058 | $235.78 | $956.8K | Form 4 |
| 2026-08-12 | Sohi Mohsen | Director | Option exercise / conversion | 4,058 | $86.23 | $349.9K | Form 4 |
| 2026-08-10 | Alegria Esther M. | Director | Grant / award / vesting (derivative) | 512 | — | $0 | Form 4 |
| 2026-08-10 | Alegria Esther M. | Director | Grant / award / vesting (derivative) | 1,506 | — | $0 | Form 4 |
| 2026-08-10 | Boulud Pierre | Director | Grant / award / vesting (derivative) | 1,025 | — | $0 | Form 4 |
| 2026-08-10 | FELDMANN CYNTHIA L | Director | Grant / award / vesting (derivative) | 512 | — | $0 | Form 4 |
| 2026-08-10 | FELDMANN CYNTHIA L | Director | Grant / award / vesting (derivative) | 1,506 | — | $0 | Form 4 |
| 2026-08-10 | HOLLAND CHRISTOPHER S | Director | Grant / award / vesting (derivative) | 1,025 | — | $0 | Form 4 |
| 2026-08-10 | Martin Paul Edward | Director | Grant / award / vesting (derivative) | 512 | — | $0 | Form 4 |
| 2026-08-10 | Martin Paul Edward | Director | Grant / award / vesting (derivative) | 1,506 | — | $0 | Form 4 |
| 2026-08-10 | Shah Nirav R | Director | Grant / award / vesting (derivative) | 512 | — | $0 | Form 4 |
| 2026-08-10 | Shah Nirav R | Director | Grant / award / vesting (derivative) | 1,506 | — | $0 | Form 4 |
| 2026-08-10 | Shapiro Louis | Director | Grant / award / vesting (derivative) | 1,025 | — | $0 | Form 4 |
| 2026-08-10 | Sohi Mohsen | Director | Grant / award / vesting (derivative) | 1,229 | — | $0 | Form 4 |
| 2026-08-10 | Sohi Mohsen | Director | Grant / award / vesting (derivative) | 1,099 | — | $0 | Form 4 |
| 2026-07-01 | Sohi Mohsen | Director | Option exercise / conversion (derivative) | 3,781 | — | $0 | Form 4 |
| 2026-07-01 | Sohi Mohsen | Director | Shares withheld for taxes / exercise cost | 1,837 | $212.30 | $390.0K | Form 4 |
| 2026-07-01 | Sohi Mohsen | Director | Option exercise / conversion | 3,781 | $71.40 | $270.0K | Form 4 |
| 2026-06-15 | Zangerle John Adam | Officer (Sr. VP, Gen Counsel, and Sec.) | Open-market sale | 1,419 | $209.28 | $297.0K | Form 4 |
| 2026-06-05 | Carestio Daniel A | Director, Officer (President and CEO) | Open-market sale | 1,374 | $212.00 | $291.3K | Form 4 |
| 2026-06-04 | Burton Karen L | Officer (Sr. Vice Pres., CFO) | Shares withheld for taxes / exercise cost | 90 | $212.24 | $19.1K | Form 4 |
| 2026-06-04 | Carestio Daniel A | Director, Officer (President and CEO) | Open-market sale | 3,054 | $214.64 | $655.5K | Form 4 |
| 2026-06-04 | Carestio Daniel A | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 1,889 | $212.24 | $400.9K | Form 4 |
| 2026-06-04 | Fraser Mary Clare | Officer (SVP & Chief HRO) | Shares withheld for taxes / exercise cost | 600 | $212.24 | $127.3K | Form 4 |
| 2026-06-04 | Kohler Kenneth E | Officer (SVP & GM, AST) | Shares withheld for taxes / exercise cost | 150 | $212.24 | $31.8K | Form 4 |
| 2026-06-04 | Madsen Julia | Officer (Sr. VP and GM, Life Sciences) | Shares withheld for taxes / exercise cost | 195 | $212.24 | $41.4K | Form 4 |
| 2026-06-04 | Tamaro Renato | Officer (V.P. & Corporate Treasurer) | Shares withheld for taxes / exercise cost | 65 | $212.24 | $13.8K | Form 4 |
| 2026-06-04 | Zangerle John Adam | Officer (Sr. VP, Gen Counsel, and Sec.) | Shares withheld for taxes / exercise cost | 401 | $212.24 | $85.1K | Form 4 |
| 2026-06-03 | Burton Karen L | Officer (Sr. Vice Pres., CFO) | Shares withheld for taxes / exercise cost | 190 | $210.19 | $39.9K | Form 4 |
| 2026-06-03 | Carestio Daniel A | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 2,619 | $210.19 | $550.5K | Form 4 |
| 2026-06-03 | Fraser Mary Clare | Officer (SVP & Chief HRO) | Shares withheld for taxes / exercise cost | 311 | $210.19 | $65.4K | Form 4 |
| 2026-06-03 | Kohler Kenneth E | Officer (SVP & GM, AST) | Shares withheld for taxes / exercise cost | 184 | $210.19 | $38.7K | Form 4 |
| 2026-06-03 | Madsen Julia | Officer (Sr. VP and GM, Life Sciences) | Shares withheld for taxes / exercise cost | 239 | $210.19 | $50.2K | Form 4 |
| 2026-06-03 | Tamaro Renato | Officer (V.P. & Corporate Treasurer) | Shares withheld for taxes / exercise cost | 64 | $210.19 | $13.5K | Form 4 |
| 2026-06-03 | Zangerle John Adam | Officer (Sr. VP, Gen Counsel, and Sec.) | Shares withheld for taxes / exercise cost | 365 | $210.19 | $76.7K | Form 4 |
| 2026-06-02 | Breeden Richard C | Director | Option exercise / conversion (derivative) | 3,781 | — | $0 | Form 4 |
| 2026-06-02 | Breeden Richard C | Director | Open-market sale | 1,481 | $209.51 | $310.3K | Form 4 |
| 2026-06-02 | Breeden Richard C | Director | Option exercise / conversion | 3,781 | $71.40 | $270.0K | Form 4 |
| 2026-06-02 | Boulud Pierre | Director | Grant / award / vesting (derivative) | 367 | — | $0 | Form 4 |
| 2026-06-02 | Burton Karen L | Officer (Sr. Vice Pres., CFO) | Grant / award / vesting (derivative) | 18,564 | — | $0 | Form 4 |
| 2026-06-02 | Burton Karen L | Officer (Sr. Vice Pres., CFO) | Option exercise / conversion | 66 | $209.76 | $13.8K | Form 4 |
| 2026-06-02 | Burton Karen L | Officer (Sr. Vice Pres., CFO) | Grant / award / vesting | 5,325 | — | $0 | Form 4 |
| 2026-06-02 | Carestio Daniel A | Director, Officer (President and CEO) | Grant / award / vesting (derivative) | 82,740 | — | $0 | Form 4 |
| 2026-06-02 | Carestio Daniel A | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 995 | $209.76 | $208.7K | Form 4 |
| 2026-06-02 | Carestio Daniel A | Director, Officer (President and CEO) | Grant / award / vesting | 23,736 | — | $0 | Form 4 |
| 2026-06-02 | Fraser Mary Clare | Officer (SVP & Chief HRO) | Grant / award / vesting (derivative) | 10,492 | — | $0 | Form 4 |
| 2026-06-02 | Fraser Mary Clare | Officer (SVP & Chief HRO) | Shares withheld for taxes / exercise cost | 591 | $209.76 | $124.0K | Form 4 |
| 2026-06-02 | Fraser Mary Clare | Officer (SVP & Chief HRO) | Grant / award / vesting | 3,009 | — | $0 | Form 4 |
| 2026-06-02 | Kohler Kenneth E | Officer (SVP & GM, AST) | Grant / award / vesting (derivative) | 7,668 | — | $0 | Form 4 |
| 2026-06-02 | Kohler Kenneth E | Officer (SVP & GM, AST) | Shares withheld for taxes / exercise cost | 66 | $209.76 | $13.8K | Form 4 |
| 2026-06-02 | Kohler Kenneth E | Officer (SVP & GM, AST) | Grant / award / vesting | 2,199 | — | $0 | Form 4 |
| 2026-06-02 | Madsen Julia | Officer (Sr. VP and GM, Life Sciences) | Grant / award / vesting (derivative) | 8,080 | — | $0 | Form 4 |
| 2026-06-02 | Madsen Julia | Officer (Sr. VP and GM, Life Sciences) | Shares withheld for taxes / exercise cost | 127 | $209.76 | $26.6K | Form 4 |
| 2026-06-02 | Madsen Julia | Officer (Sr. VP and GM, Life Sciences) | Grant / award / vesting | 2,316 | — | $0 | Form 4 |
| 2026-06-02 | Majors Cary L | Officer (SVP and President, Healthcare) | Grant / award / vesting (derivative) | 16,548 | — | $0 | Form 4 |
| 2026-06-02 | Majors Cary L | Officer (SVP and President, Healthcare) | Shares withheld for taxes / exercise cost | 67 | $209.76 | $14.1K | Form 4 |
| 2026-06-02 | Majors Cary L | Officer (SVP and President, Healthcare) | Grant / award / vesting | 4,746 | — | $0 | Form 4 |
| 2026-06-02 | McGowan Lindsey | Officer (VP, Chf. Comp. & Quality Offc.) | Grant / award / vesting (derivative) | 4,036 | — | $0 | Form 4 |
| 2026-06-02 | McGowan Lindsey | Officer (VP, Chf. Comp. & Quality Offc.) | Shares withheld for taxes / exercise cost | 329 | $209.76 | $69.0K | Form 4 |
| 2026-06-02 | McGowan Lindsey | Officer (VP, Chf. Comp. & Quality Offc.) | Grant / award / vesting | 1,155 | — | $0 | Form 4 |
| 2026-06-02 | Tamaro Renato | Officer (V.P. & Corporate Treasurer) | Grant / award / vesting (derivative) | 2,620 | — | $0 | Form 4 |
| 2026-06-02 | Tamaro Renato | Officer (V.P. & Corporate Treasurer) | Shares withheld for taxes / exercise cost | 41 | $209.76 | $8.6K | Form 4 |
| 2026-06-02 | Tamaro Renato | Officer (V.P. & Corporate Treasurer) | Grant / award / vesting | 750 | — | $0 | Form 4 |
| 2026-06-02 | Zangerle John Adam | Officer (Sr. VP, Gen Counsel, and Sec.) | Grant / award / vesting (derivative) | 15,200 | — | $0 | Form 4 |
| 2026-06-02 | Zangerle John Adam | Officer (Sr. VP, Gen Counsel, and Sec.) | Shares withheld for taxes / exercise cost | 247 | $209.76 | $51.8K | Form 4 |
| 2026-06-02 | Zangerle John Adam | Officer (Sr. VP, Gen Counsel, and Sec.) | Grant / award / vesting | 4,359 | — | $0 | Form 4 |
| 2026-06-01 | Burton Karen L | Officer (Sr. Vice Pres., CFO) | Shares withheld for taxes / exercise cost | 99 | — | $0 | Form 4 |
| 2026-06-01 | Carestio Daniel A | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 1,254 | — | $0 | Form 4 |
| 2026-06-01 | Fraser Mary Clare | Officer (SVP & Chief HRO) | Shares withheld for taxes / exercise cost | 673 | — | $0 | Form 4 |
| 2026-06-01 | Kohler Kenneth E | Officer (SVP & GM, AST) | Shares withheld for taxes / exercise cost | 109 | — | $0 | Form 4 |
| 2026-06-01 | Madsen Julia | Officer (Sr. VP and GM, Life Sciences) | Shares withheld for taxes / exercise cost | 208 | — | $0 | Form 4 |
| 2026-06-01 | Majors Cary L | Officer (SVP and President, Healthcare) | Shares withheld for taxes / exercise cost | 768 | — | $0 | Form 4 |
| 2026-06-01 | McGowan Lindsey | Officer (VP, Chf. Comp. & Quality Offc.) | Shares withheld for taxes / exercise cost | 198 | — | $0 | Form 4 |
| 2026-06-01 | Tamaro Renato | Officer (V.P. & Corporate Treasurer) | Shares withheld for taxes / exercise cost | 81 | — | $0 | Form 4 |
| 2026-06-01 | Zangerle John Adam | Officer (Sr. VP, Gen Counsel, and Sec.) | Shares withheld for taxes / exercise cost | 337 | — | $0 | Form 4 |
Ask the chat about STE's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Steris (STE).
Last updated 2026-10-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.